Blue Jet Healthcare Limited (NSE: BLUEJET, BSE: 544009) has achieved a significant milestone in its commitment to energy efficiency. The company's Unit II in Ambernath has been recognized as an 'Excellent Energy Efficient Unit' at the prestigious 26th National Awards for Excellence in Energy Management 2025, organized by the Confederation of Indian Industry (CII).

Award Recognition

The pharmaceutical company announced this achievement through a notification to the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) on September 19, 2025. This recognition underscores Blue Jet Healthcare's dedication to sustainable practices and energy conservation in its manufacturing processes.

Implications for the Company

The award is a testament to Blue Jet Healthcare's efforts in implementing energy-efficient technologies and practices at its Ambernath facility. Such recognitions often translate to:

• Enhanced brand reputation in the pharmaceutical industry
• Potential cost savings through improved energy management
• Alignment with global sustainability goals, which can attract environmentally conscious investors and partners

Investor Relations Update

In related news, Blue Jet Healthcare has also scheduled an investor meeting as part of the Kotak Healthcare Forum. According to the company's disclosure:

The company has assured that no unpublished price-sensitive information will be disclosed during this meeting, maintaining transparency with its shareholders and the market at large.

Company's Commitment to Transparency

Blue Jet Healthcare's prompt disclosure of both the energy efficiency award and the upcoming investor meet demonstrates the company's commitment to keeping its stakeholders informed. These communications, made through official channels to the stock exchanges, reflect the company's adherence to regulatory requirements and good corporate governance practices.

As Blue Jet Healthcare continues to make strides in operational excellence and investor relations, market participants will likely keep a close eye on the company's performance and sustainability initiatives in the coming quarters.

Blue Jet Healthcare Limited has announced a significant change in its shareholding structure as part of its efforts to comply with minimum public shareholding (MPS) requirements. Akshay Bansarilal Arora, a key promoter of the company, has sold a substantial portion of his stake through an Offer for Sale (OFS) mechanism.

Stake Sale Details

Akshay Bansarilal Arora divested 10,734,529 equity shares, representing 6.19% of Blue Jet Healthcare's issued and paid-up capital. The transaction was executed over two days, September 10 and 11, on both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE).

Impact on Promoter Holding

Following this sale, the promoter group's shareholding in Blue Jet Healthcare has decreased significantly:

Regulatory Compliance

The stake sale was conducted to align with the Securities and Exchange Board of India's (SEBI) minimum public shareholding norms. These regulations require listed companies to maintain a minimum public float, ensuring broader public participation in the stock market.

Transaction Execution

The Offer for Sale was facilitated through a consortium of brokers, including:

• ICICI Securities Limited
• Kotak Securities Limited
• Motilal Oswal Financial Services Limited
• Nomura Financial Advisory and Securities (India) Private Limited

The sale was executed in accordance with SEBI's master circular dated December 30, which provides comprehensive guidelines for offer for sale of shares through the stock exchange mechanism.

Company Disclosure

Blue Jet Healthcare Limited made the disclosure of this transaction on September 12, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's Company Secretary and Compliance Officer, Sweta Poddar, signed off on the official communication to the stock exchanges.

This strategic move by Blue Jet Healthcare's promoter not only ensures regulatory compliance but also potentially increases the company's free float in the market. Investors and market watchers may want to keep an eye on any potential impacts on the stock's liquidity and trading patterns following this significant change in shareholding structure.